Skip to main content
. 2023 Feb 13;13:1114059. doi: 10.3389/fonc.2023.1114059

Table 5.

Meta-regression analysis of 18F-FDG PET/CT for colorectal liver metastasis.

Covariate Studies, n Sensitivity (95%CI) P-value Specificity (95%CI) P-value
Analysis 0.37 0.16
Patient-based 9 0.93 (0.88-0.98) 0.90 (0.83-0.97)
Lesion-based 7 0.71 (0.56-0.85) 0.89 (0.81-0.97)
Ethnicity 0.68 0.25
Asia 12 0.86 (0.77-0.95) 0.91 (0.85-0.96)
Others 4 0.84 (0.68-1.00) 0.85 (0.75-0.95)
Reference standard 0.46 0.19
Pathology 3 0.72 (0.46-0.99) 0.85 (0.76-0.95)
Pathology and/or follow-up imaging 13 0.88 (0.81-0.95) 0.90 (0.85-0.95)
Clinical indication 0.02 0.01
Initial staging and post-treatment 11 0.81 (0.70-0.92) 0.85 (0.78-0.93)
Initial staging or post-treatment 5 0.93 (0.85-1.00) 0.94 (0.88-1.00)
Study design 0.16 <0.001
Retrospective 9 0.83 (0.72-0.95) 0.84 (0.76-0.92)
Prospective 7 0.88 (0.78-0.99) 0.93 (0.88-0.98)
Image analysis <0.001 0.02
Visual 10 0.76 (0.64-0.88) 0.85 (0.79-0.92)
Quantitative 5 0.94 (0.89-1.00) 0.94 (0.87-1.00)
Iodinated contrast medium 0.41 <0.001
Yes 5 0.85 (0.71-0.99) 0.80 (0.68-0.92)
No 11 0.86 (0.76-0.95) 0.92 (0.87-0.96)